Stock screener

TYRA

Conviction 25HealthcareScan · Thu, Sep 24, 2026

Tyra Biosciences, Inc. (TYRA) closed at $22.40 (-3.57%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 40, RS Rating 91, -43.5% from its 52-week high, -16.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

TYRA$22.40-3.57%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 1.82M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Tyra Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.tyra.bio ↗
Price22.40
Change-3.57%
Gap+1.12%
Rel volume1.61×
Avg volume1.4M
Avg $ vol33.82M
SMA 2024.81
SMA 5027.07
SMA 20030.54
Price vs 50-17.25%
Price vs 200-26.65%
MA stackbearish
50/200 cross—
Supertrenddown · 27.58
RSI (14)40
MACD hist-0.01
MACD crossbear · 0d
Stoch %K / %D34 / 47
ADX (14)17
+DI / −DI23 / 30
RSI divergence—
MACD divergence—
ATR %8.93%
ADR %7.66%
52w high39.61
52w low12.54
From 52w high-43.45%
Above 52w low+78.63%
New 52w highNo
SqueezeOff
Bollinger width25.24%
%B0.12
Donchian pos34.31%
Donchian high29.56
Donchian low18.66
AVWAP (52w high)29.97
vs AVWAP high-25.27%
AVWAP (52w low)29.46
vs AVWAP low-23.96%
OBV trendDown
Chaikin MF (20)0.14
Today vs 20d1.61×
Avg vol (14d)1.82M
Avg vol (20d)1.4M
Avg $ vol (20d)33.82M
Market cap1.34B
RS Rating91 / 99
RS 3m (vs SPY)-32.09%
RS 6m (vs SPY)-55.80%
RS line new highNo
Trend template3/8
Technical rank11.6
1 week-8.31%
1 month-16.07%
3 months-27.60%
6 months-38.98%
1 year+75.96%
YTD-16.39%
P/E-11.14
P/B3.78
P/S—
P/FCF-14.03
EPS-2.01
Div yield—
ROE-33.92%
ROA-31.29%
Debt/Eq—
Current14.91
EV/EBITDA-9.55
Gross margin—
Net margin—
Rev growth—
EPS growth-38.70%
Price target47.40
Target upside111.61%
Analyst ratingBuy
Institutional109.10%
Ent. value1.26B
Revenue—
Net income-45.56M
Gross profit—
Free cash flow-95.28M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out59.47M
Employees87
ListedWed, Sep 15, 2021
Free float28.09M
Float %52.1%
Short interest9.44M
Days to cover27.1d
Short volume52.9%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.69 vs −$0.67
Last surprise-3.0% miss
Setup gradeD
Conviction25 / 100
Pattern quality—
Tech rank11.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance28.31
Support21.42
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in TYRA

All disclosures →
No recent disclosed trades by Congress in TYRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TYRA · open-market 2 buys

InsiderSideShares
Fuhrman Alan
Chief Financial Officer · Common Stock · 2026-09-15
Grant951
Harris Todd
President and CEO · Common Stock · 2026-09-15
Grant864
RA CAPITAL MANAGEMENT, L.P.
Director · Pre-Funded Warrants (Right to Buy) · 2026-09-15
Buy9.08M
Rueb Yuliya
Vice President, Finance (PAO) · Common Stock · 2026-09-15
Grant2.92K
Verjee Rehan
Director · Common Stock · 2026-09-09
Buy971.894
Shah Rajeev M.
Director · Stock Option (Right to Buy) · 2026-05-28
Grant13.16K
Kolchinsky Peter
Director · Stock Option (Right to Buy) · 2026-05-28
Grant13.16K
Simson Jake
Director · Stock Option (Right to Buy) · 2026-05-28
Grant13.16K
MORE ROBERT J
Director · Stock Option (Right to Buy) · 2026-05-28
Grant13.16K
RA Capital Nexus Fund, L.P.
Director · Stock Option (Right to Buy) · 2026-05-28
Grant13.16K

SEC filings

EDGAR filings in TYRA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.